Business Segment Information

3 Months Ended

Mar. 31, 2020

16. Business Segment Information

The Company has three reportable segments, BSI Life Science, BSI NANO and BEST, as discussed in Note 1 to the consolidated financial statements.

Revenue and operating income by reportable segment for the three months ended March 31, 2020 and 2019 are presented below (dollars in millions):


	Three Months Ended March 31,
	2020		2019
Revenue:
BSI Life Science	$	261.4	$	276.0
BSI NANO		120.1		140.8
BEST		46.2		47.8
Eliminations (a)		(3.7)		(3.2)
Total revenue	$	424.0	$	461.4

Operating Income (loss)
BSI Life Science	$	39.5	$	46.9
BSI NANO		(8.0)		3.2
BEST		1.7		3.1
Corporate, eliminations and other (b)		(16.8)		(11.3)
Total operating income	$	16.4	$	41.9

(a)	Represents product and service revenue between reportable segments.

(b)	Represents corporate costs and eliminations not allocated to the reportable segments.

Total assets by reportable segment as of March 31, 2020 and December 31, 2019 are as follows (dollars in millions):


	March 31,		December 31,
	2020		2019
Assets:
BSI Life Science, BSI NANO & Corporate	$	2,899.1	$	2,711.6
BEST		67.6		64.6
Eliminations and other (a)		(4.8)		(4.7)
Total assets	$	2,961.9	$	2,771.5

(a)	Assets not allocated to the reportable segments and eliminations of intercompany transactions.

The Company is unable, without unreasonable effort or expense to disclose the amount of total assets by BSI Life Science and BSI NANO Segments as well as the Corporate function and further, the Company’s chief operating decision maker does not receive any asset information by operating segment.